Both IQGAP1 and IQGAP3 are considered oncogenes in HCC and, thus, can serve as highly sensitive and specific biomarkers for this type of tumor, while IQGAP2 may act as a tumor suppressor [92,93]. This evidence concerns the gene IQGAP2 and hepatocellular carcinoma.